Antimicrobial Contribution of Chitosan Surface-Modified Nanoliposomes Combined with Colistin against Sensitive and Colistin-Resistant Clinical <i>Pseudomonas aeruginosa</i>

Colistin is a re-emergent antibiotic peptide used as a last resort in clinical practice to overcome multi-drug resistant (MDR) Gram-negative bacterial infections. Unfortunately, the dissemination of colistin-resistant strains has increased in recent years and is considered a public health problem wo...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Valentina Laverde-Rojas, Yamil Liscano, Sandra Patricia Rivera-Sánchez, Ivan Darío Ocampo-Ibáñez, Yeiston Betancourt, Maria José Alhajj, Cristhian J. Yarce, Constain H. Salamanca, Jose Oñate-Garzón
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2020-12-01
Seri Bilgileri:	Pharmaceutics
Konular:	colistin nanoliposomes MDR-Bacteria chitosan
Online Erişim:	https://www.mdpi.com/1999-4923/13/1/41
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!